This inventor holds 1 USPTO granted patent. Top assignee: Transgene S.a.. Active years: 2001.
Company Filing History:
Years Active: 2001
Title: Cécile Chartier: Innovator in Viral Vector Technology
Introduction
Cécile Chartier is a prominent inventor based in Strasbourg, France. He has made significant contributions to the field of gene therapy through his innovative work on viral vectors. His research focuses on methods that enhance the preparation and application of these vectors in therapeutic settings.
Latest Patents
Cécile Chartier holds a patent for a "Method for the preparation of a viral vector by intermolecular homologous recombination." This invention encompasses methods of preparing a recombinant viral vector within a prokaryotic cell through intermolecular homologous recombination. It also includes methods for preparing an infectious viral particle containing the recombinant viral vector and pharmaceutical compositions comprising the vector or particle. The therapeutic use of the vector or particle, particularly in human gene therapy, is a key aspect of this invention.
Career Highlights
Cécile Chartier is associated with Transgene S.A., a company known for its focus on innovative immunotherapy solutions. His work at Transgene has positioned him as a key player in the development of advanced therapeutic strategies using viral vectors.
Collaborations
Cécile collaborates with Eric Degryse, who is also involved in the field of viral vector technology. Their partnership enhances the research and development efforts at Transgene, contributing to the advancement of gene therapy solutions.
Conclusion
Cécile Chartier's contributions to viral vector technology and gene therapy are noteworthy. His innovative methods and collaborations continue to impact the field positively. His work exemplifies the importance of research and innovation in advancing medical therapies.